Simpler Grants.gov #HT942526TERPCTA

Army Clinical Trial Grant for Military Toxic Exposures Research

The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is soliciting applications for the FY26 Toxic Exposures Research Program (TERP) Clinical Trial Award. - Focus is on clinical trials addressing prevention, treatment, or management of symptoms, diseases, or conditions linked to military-related toxic exposures - Open to a broad range of applicants, including those proposing interdisciplinary collaborations - Partnering Principal Investigator Option allows two PIs to be named on separate awards - No specific OEMs or vendors are named, as this is a grant for research and clinical trial execution - Funded under Assistance Listing 12.420 (Military Medical Research and Development) - Total program funding is $4,500,000 - Solicitation number: HT942526TERPCTA - No unique product or service requirements beyond the focus on clinical trials for military toxic exposures

Description

The fiscal year 2026 Toxic Exposures Research Program Clinical Trial Award supports clinical trials aimed at preventing, treating, or managing symptoms, diseases, or conditions related to military toxic exposures. Projects can range from small proof-of-concept trials to large-scale efficacy trials in relevant patient populations. The program encourages interdisciplinary collaborations through a Partnering Principal Investigator Option, allowing two PIs to be named on separate awards to accelerate clinical applications. The award is funded by the Department of the Army and aims to advance military medical research and development.

View original listing